Medicamen Statements
ME
Data from Medicamen`s earning releases including common size income statement and balance sheet.
Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.
Key Information:
Report currency:
INR - Indian rupee
Last reporting period:
31 Mar, 2024
Next reporting period:
27 Sep, 2024
Report frequency:
Semi-annual
Earnings release date:
—
Expected release date:
08 Nov, 2024
Medicamen Income Statement
B
M
INR (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
938.22
-26.4 %
100
485.79
49.9
452.43
-27.7 %
50.1
—
0
164.04
17.7
381.78
-22.4 %
41.7
70.646
-47.1 %
8.4
-25.335
-4
13.967
1.2
59.278
-49.9 %
5.6
18.575
1.3
41.577
-62 %
4.5
3.21
12.952
1 274.28
71.6 %
100
648.86
51.5
625.42
75.6 %
48.5
—
0
202.26
16
491.98
85.8 %
39.1
133.43
45.9 %
9.5
-28.202
-2.2
13.082
1.1
118.31
37.9 %
8.4
24.604
2
109.5
43.1 %
7.9
8.022
13.602
742.47
11.4 %
100
386.28
56
356.19
7.4 %
44
—
0
114.55
15
264.77
6.8 %
31.4
91.424
9.3 %
12.6
-15.395
-2.2
9.752
0.9
85.781
1.3 %
11.3
10.392
1.5
76.545
6.5 %
10.1
6.259
12.249
666.2
20.3 %
100
334.65
49.4
331.55
13.6 %
50.6
—
0
92.533
14.6
247.92
18.1 %
38
83.631
2.2 %
12.6
-13.832
-1.8
14.87
1.6
84.669
2.1 %
12.4
12.773
1.6
71.896
10.2 %
10.7
5.79
12.421
553.95
-7.8 %
100
262.19
46.2
291.76
-14 %
53.8
—
0
78.012
18.4
209.89
-13.7 %
38.7
81.869
-14.6 %
15.1
-10.568
-2.5
11.651
1.5
82.952
-15.3 %
14.1
17.713
2.1
65.239
-22.1 %
12.1
5.332
12.236
600.5
—
100
261.35
42.6
339.15
—
57.4
—
0
70.417
12.7
243.28
—
42.4
95.877
—
15
-3.438
-0.9
5.55
1.5
97.989
—
15.5
14.258
2.6
83.731
—
13
6.856
12.213